Literature DB >> 22001902

Langerhans cell histiocytosis: a cytokine/chemokine-mediated disorder?

Lara Garabedian1, Sofie Struyf, Ghislain Opdenakker, Silvano Sozzani, Jo Van Damme, Geneviève Laureys.   

Abstract

Langerhans cell histiocytosis (LCH) is a rare disorder characterized by an abnormal accumulation and/or proliferation of cells with a Langerhans cell phenotype. Although no clear cause of LCH has been identified, it has been postulated that LCH might be the consequence of an immune dysregulation, causing Langerhans cells to migrate to and accumulate at various sites. Production of cytokines and chemokines is a central feature of immune regulation. Cytokines are abundantly present within LCH lesions. We review here the potential role of cytokines and chemokines in the pathogenesis of LCH. The type, distribution, and number of different cytokines released within lesions can provide clues to the possible aetiology of LCH and, ultimately, might offer therapeutic possibilities using recombinant cytokines or antagonists for this disorder.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22001902     DOI: 10.1684/ecn.2011.0290

Source DB:  PubMed          Journal:  Eur Cytokine Netw        ISSN: 1148-5493            Impact factor:   2.737


  5 in total

1.  Prognostic significance of gelsolin and MMP12 in Langerhans cell histiocytosis.

Authors:  Jong-Jin Seo; Taeshik Cho; Sun-Young Kim; Ibrahim Nassour; Hee-Jin Kim; Yeon-Jung Lim; Kyung-Nam Koh; Ho-Joon Im
Journal:  Korean J Hematol       Date:  2012-12-24

2.  Langerhans cell histiocytosis in Chinese adults: absence of BRAF mutations and increased FOXP3(+) regulatory T cells.

Authors:  Chunguang Tong; Xingyuan Jia; Yanjun Jia; Yanling He
Journal:  Int J Clin Exp Pathol       Date:  2014-05-15

3.  Expression pattern of serum cytokines in hepatitis B virus infected patients with persistently normal alanine aminotransferase levels.

Authors:  Dengming He; Maoshi Li; Shimin Guo; Peng Zhu; Hongfei Huang; Guohua Yan; Quanxin Wu; Shiqi Tao; Zhaoxia Tan; Yuming Wang
Journal:  J Clin Immunol       Date:  2013-08-17       Impact factor: 8.317

4.  Expression profiles of circulating cytokines, chemokines and immune cells in patients with hepatitis B virus infection.

Authors:  Jian-Qi Lian; Xiao-Fei Yang; Rong-Rong Zhao; Yan-Yan Zhao; Yu Li; Ye Zhang; Chang-Xing Huang
Journal:  Hepat Mon       Date:  2014-06-07       Impact factor: 0.660

Review 5.  Bone metabolism in Langerhans cell histiocytosis.

Authors:  Athanasios D Anastasilakis; Marina Tsoli; Gregory Kaltsas; Polyzois Makras
Journal:  Endocr Connect       Date:  2018-07-02       Impact factor: 3.335

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.